Emeis S.A (EMEIS) | Stock Overview & Key Data
Emeis S.A. | Large-cap | Healthcare
Emeis S.A. | Large-cap | Healthcare
Emeis S.A Performance Comparison
Stock Range
Today's Range
Low: €12.83
High: €13.68
on August 4, 2025
52 Week Range
Low: €4.44
High: €14.22
on December 17, 2024
on July 31, 2025
All-Time High: €8,238.46 on February 17, 2020
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€2.2B
EPS
-2.62
P/E Ratio (TTM)
0.02
Forward P/E
-687.00
P/B Ratio
1.28
PEG Ratio
-687.00
Div. Yield
N/A
ROE
-23.02%
Beta
0.744
Debt to Equity
514.45
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
0.54%
Profit Margin
-7.31%
Returns and Earnings
Return on Assets (TTM)
0.01%
Return on Equity (TTM)
-23.02%
EBITDA
€718.7M
Net Income (TTM)
€-412.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€34.94
Quarterly Revenue Growth (YoY)
7.70%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Emeis S.A EMEIS | 2.22B Large-cap | 18.55% | 24.34% | 12.16% | 106.62% | 125.99% | 36.44% | -99.12% | -99.80% |
| Orpea ORP | 1.96B Mid-cap | 18.55% | 24.34% | 12.16% | 106.62% | 125.99% | 36.44% | -99.12% | -99.80% |
| Clariene SE CLARI | 1.62B Large-cap | -10.69% | -14.97% | 13.59% | 96.02% | 106.05% | 146.11% | -42.09% | -42.09% |
| Ramsay Générale de GDS | 1.16B Large-cap | -2.34% | -4.13% | 7.51% | -2.34% | -18.36% | -31.92% | -51.17% | -38.89% |
| Lna Santé S.A LNA | 292.46M Mid-cap | 4.43% | 10.12% | 22.51% | 28.64% | 17.67% | 13.43% | -14.11% | -44.29% |
| EssilorLuxottica EL | 117.73B Large-cap | 2.24% | 8.68% | -0.85% | -3.30% | 9.01% | 22.50% | 59.41% | 133.58% |
Ownership & Short Interest
Insider Ownership
0.00%
Institutional Ownership
56.09%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
856K
Average 90-Day Volume
627K
Emeis S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Emeis S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EMEIS's 52-week high and low?
- In the last 52 weeks, Emeis S.A reached a high of €14.22 (on July 31, 2025) and a low of €4.44 (on December 17, 2024).
- What is the market cap and P/E ratio for EMEIS?
- Curious about Emeis S.A's size and valuation? Its market capitalization stands at 2.22B. When it comes to valuation, the P/E ratio (trailing twelve months) is 0.02, and the forward P/E (looking ahead) is -687.00.
- Does EMEIS pay dividends? If so, what's the yield?
- As for dividends, Emeis S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Emeis S.A's main competitors or similar companies to consider before investing?
When looking at Emeis S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Orpea
ORP1.96B Healthcare Medical Care Facilities 36.44% -99.12% Clariene SE
CLARI1.62B Healthcare Medical Care Facilities 146.11% -42.09% Ramsay Générale de
GDS1.16B Healthcare Medical Care Facilities -31.92% -51.17% Lna Santé S.A
LNA292.46M Healthcare Medical Care Facilities 13.43% -14.11% EssilorLuxottica
EL117.73B Healthcare Medical Instruments & Supplies 22.50% 59.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Emeis S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Emeis S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -23.02%, the Debt to Equity ratio from the most recent quarter is 514.45, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for EMEIS?
- Looking at Emeis S.A's growth, its revenue over the trailing twelve months (TTM) was €6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.70%, and quarterly earnings saw a YoY growth of N/A.
- How much of EMEIS stock is held by insiders and institutions?
- Wondering who owns Emeis S.A stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 56.09%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.